Bionano Genomics Reports Widened Q1 Loss, Reiterates Going Concern Warning Amid Cash Burn
BNGO sits 23% above its 52-week low of $1.06.
Summary
Bionano Genomics reported a significantly increased net loss for Q1 2026 and reiterated its going concern warning, citing substantial doubt about its ability to continue operations without additional funding. The company faces a high cash burn and a maturing debt obligation, despite recent ATM sales and a new shelf registration.
Key Events · Earnings and Guidance · BNGO
-
Reiterates Going Concern Warning
Management explicitly states 'substantial doubt about the Company's ability to continue as a going concern' within twelve months due to recurring losses and negative cash flows.
-
Net Loss Widens Significantly
Q1 2026 net loss increased to $8.3 million, a 168% increase compared to a $3.1 million net loss in Q1 2025.
-
Increased Cash Burn
Cash used in operating activities rose to $5.7 million in Q1 2026, up from $2.8 million in Q1 2025, further straining liquidity.
-
Limited Cash Runway
As of March 31, 2026, the company had $3.4 million in cash and cash equivalents and $11.0 million in short-term investments, providing a short runway given the current burn rate.
Analysis · BNGO · Industrial Applications And Services
Bionano Genomics' Q1 2026 results highlight severe liquidity challenges, with the company explicitly stating 'substantial doubt about its ability to continue as a going concern' within the next twelve months. The net loss significantly widened to $8.3 million, and cash used in operations increased to $5.7 million, further depleting its limited cash reserves. While a new $400 million shelf registration was filed, its immediate utility is constrained by the company's low market capitalization, limiting the amount of capital that can be raised. The upcoming maturity of $10.3 million in convertible debentures adds immediate financial pressure, necessitating urgent capital raises to avoid potential bankruptcy.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 41.9% of the 327 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.46%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BNGO was trading at $1.30 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $13.9M. The 52-week trading range was $1.06 to $5.50. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.